Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1064691

registered interest
date	21/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Diseases: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the NHS Long Term Plan, what the timeframe is for the introduction of lung health checks in Southampton Care Commissioning Group.
tabling member constituency	Southampton, Itchen
tabling member printed	Royston Smith
uin	224354
answer	answer is ministerial correction date of answer 28/02/2019 answer text <p>Local areas are beginning to work up plans for the implementation of lung health checks in their area, and funding has been made available to enable projects to start in 2019-20. Total costs are just under £70 million and will pay for nurses, radiographers and radiologists to provide lung health check appointments and low dose computed tomography (CT) scans.</p><p> </p><p>In the ten initial roll-out sites which include Wessex Cancer Alliance (Southampton Care Commissioning Group) there are approximately 600,000 eligible patients, who between them will require a total of 200,000 CT scans.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 28/02/2019 11:51:35 answering member 4067 label Biography information for Steve Brine
tabling member	4478 label Biography information for Royston Smith

1028653

registered interest
date	19/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Alcoholic Drinks: Minimum Unit Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the effect of the introduction of minimum unit pricing for alcohol in Scotland on (a) the level of consumption of alcohol and (b) public health.
tabling member constituency	Southampton, Itchen
tabling member printed	Royston Smith
uin	203934
answer	answer is ministerial correction date of answer 09/01/2019 answer text <p>No assessment has been made of the effect of the introduction of minimum unit pricing of alcohol in Scotland. The introduction of minimum unit pricing in England remains under review.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 09/01/2019 15:08:15 answering member 4067 label Biography information for Steve Brine
tabling member	4478 label Biography information for Royston Smith

1023205

registered interest
date	11/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Multiple Sclerosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what (a) treatments and (b) support is provided by the NHS to people with progressive multiple sclerosis.
tabling member constituency	Southampton, Itchen
tabling member printed	Royston Smith
uin	201225
answer	answer is ministerial correction date of answer 19/12/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) provides a range of guidance on the treatment and management of multiple sclerosis (MS), including information on the use of disease modifying therapies for use in the National Health Service for the treatment of patients with relapsing remitting MS; the most common form of the disease. NICE also highlights the importance of involving professionals who can meet the needs of the patient in the best way, such as physiotherapists and occupational therapists. In January 2016, NICE published an MS Quality Standard. This includes the Quality Statement: “Adults with MS are offered a comprehensive review at least once a year by healthcare professionals with expertise in MS.”</p><p> </p><p>Once diagnosed, and with a management strategy in place, the majority of people with MS can be cared for through routine access to primary and secondary care. However, NHS England also commissions the specialised elements of MS care that patients may need. These services are provided at 25 specialised neurological treatment centres across England. NHS England has published a service specification setting out what providers must have in place to deliver specialised neurological care, including equity of access to services for patients wherever they live. The specification can be found via the following link:</p><p> </p><p><a href="http://www.england.nhs.uk/commissioning/spec-services/npc-crg/group-d/d04/" target="_blank">www.england.nhs.uk/commissioning/spec-services/npc-crg/group-d/d04/</a></p><p> </p><p>The Department does not collect information on the number of people with MS. Various studies have estimated numbers at around 100,000 people in the United Kingdom. The NICE guideline ‘Multiple sclerosis: management of multiple sclerosis in primary and secondary care’, published in 2014, uses this estimate and breaks this down for the three types of MS: relapsing remitting (affecting about 85% of those diagnosed); secondary progressive which can come after relapsing remitting, and primary progressive (affecting 10-15% of those diagnosed).</p><p> </p><p>On the available information it does not appear that the Department centrally directly financially supports any charity or third sector organisations related to MS. The Department does not make any financial help specifically available for those with MS. Those with MS have the same entitlement on grounds of low income to help with NHS costs as other individuals.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 201226 201227 question first answered 19/12/2018 11:56:31 answering member 4067 label Biography information for Steve Brine
tabling member	4478 label Biography information for Royston Smith

1023206

registered interest
date	11/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Multiple Sclerosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of people who have progressive multiple sclerosis.
tabling member constituency	Southampton, Itchen
tabling member printed	Royston Smith
uin	201226
answer	answer is ministerial correction date of answer 19/12/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) provides a range of guidance on the treatment and management of multiple sclerosis (MS), including information on the use of disease modifying therapies for use in the National Health Service for the treatment of patients with relapsing remitting MS; the most common form of the disease. NICE also highlights the importance of involving professionals who can meet the needs of the patient in the best way, such as physiotherapists and occupational therapists. In January 2016, NICE published an MS Quality Standard. This includes the Quality Statement: “Adults with MS are offered a comprehensive review at least once a year by healthcare professionals with expertise in MS.”</p><p> </p><p>Once diagnosed, and with a management strategy in place, the majority of people with MS can be cared for through routine access to primary and secondary care. However, NHS England also commissions the specialised elements of MS care that patients may need. These services are provided at 25 specialised neurological treatment centres across England. NHS England has published a service specification setting out what providers must have in place to deliver specialised neurological care, including equity of access to services for patients wherever they live. The specification can be found via the following link:</p><p> </p><p><a href="http://www.england.nhs.uk/commissioning/spec-services/npc-crg/group-d/d04/" target="_blank">www.england.nhs.uk/commissioning/spec-services/npc-crg/group-d/d04/</a></p><p> </p><p>The Department does not collect information on the number of people with MS. Various studies have estimated numbers at around 100,000 people in the United Kingdom. The NICE guideline ‘Multiple sclerosis: management of multiple sclerosis in primary and secondary care’, published in 2014, uses this estimate and breaks this down for the three types of MS: relapsing remitting (affecting about 85% of those diagnosed); secondary progressive which can come after relapsing remitting, and primary progressive (affecting 10-15% of those diagnosed).</p><p> </p><p>On the available information it does not appear that the Department centrally directly financially supports any charity or third sector organisations related to MS. The Department does not make any financial help specifically available for those with MS. Those with MS have the same entitlement on grounds of low income to help with NHS costs as other individuals.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 201225 201227 question first answered 19/12/2018 11:56:31 answering member 4067 label Biography information for Steve Brine
tabling member	4478 label Biography information for Royston Smith

1023207

registered interest
date	11/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Multiple Sclerosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what financial assistance his Department makes available to (a) organisations dealing with multiple sclerosis and (b) individuals who have multiple sclerosis.
tabling member constituency	Southampton, Itchen
tabling member printed	Royston Smith
uin	201227
answer	answer is ministerial correction date of answer 19/12/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) provides a range of guidance on the treatment and management of multiple sclerosis (MS), including information on the use of disease modifying therapies for use in the National Health Service for the treatment of patients with relapsing remitting MS; the most common form of the disease. NICE also highlights the importance of involving professionals who can meet the needs of the patient in the best way, such as physiotherapists and occupational therapists. In January 2016, NICE published an MS Quality Standard. This includes the Quality Statement: “Adults with MS are offered a comprehensive review at least once a year by healthcare professionals with expertise in MS.”</p><p> </p><p>Once diagnosed, and with a management strategy in place, the majority of people with MS can be cared for through routine access to primary and secondary care. However, NHS England also commissions the specialised elements of MS care that patients may need. These services are provided at 25 specialised neurological treatment centres across England. NHS England has published a service specification setting out what providers must have in place to deliver specialised neurological care, including equity of access to services for patients wherever they live. The specification can be found via the following link:</p><p> </p><p><a href="http://www.england.nhs.uk/commissioning/spec-services/npc-crg/group-d/d04/" target="_blank">www.england.nhs.uk/commissioning/spec-services/npc-crg/group-d/d04/</a></p><p> </p><p>The Department does not collect information on the number of people with MS. Various studies have estimated numbers at around 100,000 people in the United Kingdom. The NICE guideline ‘Multiple sclerosis: management of multiple sclerosis in primary and secondary care’, published in 2014, uses this estimate and breaks this down for the three types of MS: relapsing remitting (affecting about 85% of those diagnosed); secondary progressive which can come after relapsing remitting, and primary progressive (affecting 10-15% of those diagnosed).</p><p> </p><p>On the available information it does not appear that the Department centrally directly financially supports any charity or third sector organisations related to MS. The Department does not make any financial help specifically available for those with MS. Those with MS have the same entitlement on grounds of low income to help with NHS costs as other individuals.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 201225 201226 question first answered 19/12/2018 11:56:31 answering member 4067 label Biography information for Steve Brine
tabling member	4478 label Biography information for Royston Smith

1015543

registered interest
date	27/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pulmonary Arterial Hypertension
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to support people with pulmonary hypertension.
tabling member constituency	Southampton, Itchen
tabling member printed	Royston Smith
uin	196300
answer	answer is ministerial correction date of answer 05/12/2018 answer text <p>NHS England commissions a national Pulmonary Arterial Hypertension (PAH) service with six adult centres and one children’s service.</p><p> </p><p>The services are required to meet the standards set out in the national service specifications which describe the teams and service are organised, including shared care arrangements. These clinical teams support patients through diagnosis, treatment and ongoing care. These policies are on the NHS England website at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/commissioning/spec-services/npc-crg/group-a/a01/" target="_blank">https://www.england.nhs.uk/commissioning/spec-services/npc-crg/group-a/a01/</a></p><p> </p><p>NHS England as a commissioner sets the model of service it expects hospitals to deliver for specialised PAH services. This is monitored through contractual processes. This states for PAH that as well as medical expertise other support, including nurse specialists, supportive care, shared care arrangements and palliative care will be available. If more detail is required on specific types of support that is provided, this would need to be sought from hospitals or from clinical commissioning groups as commissioners of non-specialised parts of the pathway</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/12/2018 16:41:40 answering member 4067 label Biography information for Steve Brine
tabling member	4478 label Biography information for Royston Smith

1015548

registered interest
date	27/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pulmonary Arterial Hypertension
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the average waiting time for a diagnosis of pulmonary hypertension was in the last year for which data is available.
tabling member constituency	Southampton, Itchen
tabling member printed	Royston Smith
uin	196302
answer	answer is ministerial correction date of answer 05/12/2018 answer text <p>NHS England commissions the National Audit of Pulmonary Hypertension (NAPH), which measures the quality of care provided to people referred to Pulmonary Hypertension services in England, including patients referred from Wales, and Scotland.</p><p> </p><p>According to the recently published NAPH ninth annual report, in 2017/18, 98% of new patients continue to be diagnosed within six months of referral, against a target of 95%. This is the same as the figure for 2016/17.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/12/2018 16:38:45 answering member 4067 label Biography information for Steve Brine
tabling member	4478 label Biography information for Royston Smith

1015550

registered interest
date	27/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pulmonary Arterial Hypertension
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what treatments are available on the NHS for pulmonary hypertension; and what assessment he has made of the adequacy of the accessibility of those treatments.
tabling member constituency	Southampton, Itchen
tabling member printed	Royston Smith
uin	196303
answer	answer is ministerial correction date of answer 05/12/2018 answer text <p>A number of treatments are available for pulmonary hypertension (PH). If PH is caused by another condition, such as a heart or lung problem, treatments will focus on the underlying condition. The full range of treatments for PH is detailed on the NHS website at the following link:</p><p> </p><p><a href="https://www.nhs.uk/conditions/pulmonary-hypertension/treatment/" target="_blank">https://www.nhs.uk/conditions/pulmonary-hypertension/treatment/</a></p><p> </p><p>NHS England commissions specialised PH services through the Specialised Respiratory Clinical Reference Group (CRG), which are available to all patients whose care is overseen by a specialist pulmonary arterial hypertension (PAH) centre in England.</p><p> </p><p>The policies regarding these specialised services are published on the NHS England Specialised Respiratory Clinical Reference Group website at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/commissioning/spec-services/npc-crg/group-a/a01/" target="_blank">https://www.england.nhs.uk/commissioning/spec-services/npc-crg/group-a/a01/</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/12/2018 16:49:17 answering member 4067 label Biography information for Steve Brine
tabling member	4478 label Biography information for Royston Smith

947287

registered interest
date	24/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what proportion of patients pay the full price for their prescription medicine.
tabling member constituency	Southampton, Itchen
tabling member printed	Royston Smith
uin	168190
answer	answer is ministerial correction date of answer 10/09/2018 answer text <p>National Health Service patients pay a fixed charge for each prescription item dispensed in primary care, unless they are exempt from prescription charges. Prescription prepayment certificates allow people who need regular NHS prescriptions to cap the cost by paying a fixed amount for an unlimited number of items. We estimate that on average 90% of NHS prescriptions are dispensed free of charge. Data is not available on what patients pay for private prescriptions.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 10/09/2018 16:53:53 answering member 4067 label Biography information for Steve Brine
tabling member	4478 label Biography information for Royston Smith

947288

registered interest
date	24/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the cost to the public purse was of a) subsidising prescriptions for people who do not pay the fixed rate for prescriptions, and b) paying the difference between cost of prescription medicines and the fixed rates paid for them by people who are not entitled to help with the cost of prescriptions, over the last twelve months for which data is available.
tabling member constituency	Southampton, Itchen
tabling member printed	Royston Smith
uin	168191
answer	answer is ministerial correction date of answer 10/09/2018 answer text <p>The following table shows the net ingredient cost (NIC) of drugs for both patients who pay a prescription charge and patients who are exempt from prescription charges, including those with a valid prescription prepayment certificate (PPC).</p><p> </p><table><tbody><tr><td colspan="2"><p>Drug cost split by prescription charge status (April 2017 - March 2018)</p></td></tr><tr><td><p> </p></td><td><p>Total net ingredient cost (£ million)</p></td></tr><tr><td><p>Prescribing identified as attracting a prescription charge</p></td><td><p>503.1</p></td></tr><tr><td><p>Prescribing identified as exempt from prescription charges (including PPC exemption)</p></td><td><p>8,526.2</p></td></tr></tbody></table><p> </p><p>The following table shows the NIC and the revenue collected for all prescriptions where the patient has made some form of payment in terms of either a prescription charge at the point of dispensing or via a PPC.</p><p> </p><p> </p><table><tbody><tr><td colspan="5"><p><br> Drug cost for prescribing associated with some form of customer payment and revenue collected from prescription charges and PPCs<br> (April 2017 - March 2018)</p></td></tr><tr><td><p> </p></td><td><p>Total net ingredient cost (£ million)</p></td><td><p>Revenue collected for prescription charges (£ million)</p></td><td><p>Revenue collected for PPCs (£ million)</p></td><td><p>Total drug costs minus revenue collected (£ million)</p></td></tr><tr><td><p>Prescribing identified as attracting a prescription charge</p></td><td><p>503.1</p></td><td><p>470.5</p></td><td><p>n/a</p></td><td rowspan="2"><p>400.0</p></td></tr><tr><td><p>Prescribing identified as exempt from prescription charges based on a PPC exemption</p></td><td><p>516.8</p></td><td><p>n/a</p></td><td><p>149.4</p></td></tr></tbody></table><p> </p><p> </p><p>Note: The National Health Service prescription charge was £8.60 for each prescribed item for the time period financial year 2017/18</p> answering member constituency Winchester answering member printed Steve Brine question first answered 10/09/2018 16:56:45 answering member 4067 label Biography information for Steve Brine
tabling member	4478 label Biography information for Royston Smith